Lokhorst, H. M., Schmidt-Wolf, I., Sonneveld, P., van der Holt, B., Martin, H., Barge, R., Bertsch, U., Schlenzka, J., Bos, G. M., Croockewit, S., Zweegman, S., Breitkreutz, I., Joosten, P., Scheid, C., van Marwijk-Kooy, M., Salwender, H.-J., van Oers, M. H., Schaafsma, R., Naumann, R., Sinnige, H., Blau, I., Delforge, M., de Weerdt, O., Wijermans, P., Wittebol, S., Duersen, U., Vellenga, E. and Goldschmidt, H. (2007) “Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma”, Haematologica. Pavia, Italy, 93(1), pp. 124-127. doi: 10.3324/haematol.11644.